AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Influence of Vertical Implant Position on Marginal Bone Loss in Cases With Thin Phenotype

RecruitingNAAges 18 Years - anyAllCairo University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if vertical position of the dental implant will affect the bone around the implant in place of a missing tooth that happens to be bounded by two natural teeth. It will also measure esthetics and patient satisfaction. The main questions it aims to answer are: Does vertical implant position below the crest of the bone lead to less marginal bone loss? Will it affect implant survival as well as quality of soft tissue, esthetics and patient satisfaction? Participants will: Have an implant placed at the bone level or 2 mm below the bone level Visit the clinic once every 3 months for checkups, radiographs, and readings

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with single missing upper anterior or premolar teeth * Patients with minimum buccolingual width of 6 mm and mesiodistal width of 6 mm * Patients with thin soft tissue phenotype * Patients with healthy systemic conditions. * Patients older than 18 years. * Good oral hygiene. * Cooperative patients who accept a one-year follow-up period. * Patients who consent to being part of the study (sign an informed consent form). * Adequate inter-arch space for implant placement. * Favorable occlusion (no traumatic occlusion). * Absence of allergy to the prescribed medications. Exclusion Criteria: * Patients with inadequate bone volume and/ or quality * Patients with local root remnants * Patients with inadequate wound healing * Patients with signs of acute infection related to the area of interest. * Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits (Lobbezoo et al., 2006). * Heavy smokers (more than 10 cigarettes per day) (Lambert, Morris and Ochi, 2000). * Metabolic diseases such as diabetes or hyperthyroidism as well as systemic medications such as chemotherapy or bisphosphonates * Pregnant or nursing women. * Uncooperative patients.
๐Ÿ’Š

What it tests

  • Delayed implant with immediate temporization placed 2 mm subcrestal level
  • Delayed implant with immediate temporization placed at the crestal level
๐Ÿ“

Where

1 site
Cairo University
Cairo, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy